# Crispr Therapeutics' stock soars 10% as FDA-panel meeting raises hopes sickle-cell-disease drug will be approved
**Why is it moving?**

**2023-11-01 17:16**

**https://www.ainvest.com/news/crispr-therapeutics-stock-soars-10-as-fda-panel-meeting-raises-hopes-sickle-cell-disease-drug-will-be-approved-231110004d776c2d8b3c9113/**

Crispr Therapeutics' stock soars 10% as FDA-panel meeting raises hopes sickle-cell-disease drug will be approved